176 related articles for article (PubMed ID: 23645841)
21. Assessment of Mixed
Arisue N; Chagaluka G; Palacpac NMQ; Johnston WT; Mutalima N; Peprah S; Bhatia K; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Goedert JJ; Molyneux EM; Newton R; Horii T; Mbulaiteye SM
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918470
[TBL] [Abstract][Full Text] [Related]
22. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda.
Kirimunda S; Verboom M; Otim I; Ssennono M; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Kinyera T; Mwebaza I; Joloba M; Ayers LW; Reynolds SJ; Bhatia K; Onabajo OO; Hallensleben M; Biggar RJ; Prokunina-Olsson L; Goedert JJ; Blasczyk R; Mbulaiteye SM
Br J Haematol; 2020 May; 189(3):489-499. PubMed ID: 32072624
[TBL] [Abstract][Full Text] [Related]
23. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya.
Chelimo K; Ofulla AV; Narum DL; Kazura JW; Lanar DE; John CC
Pediatr Infect Dis J; 2005 Aug; 24(8):680-4. PubMed ID: 16094220
[TBL] [Abstract][Full Text] [Related]
25. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
Taylor RR; Allen SJ; Greenwood BM; Riley EM
Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
[TBL] [Abstract][Full Text] [Related]
26. Genetic diversity in merozoite surface protein (MSP)-1 and MSP-2 genes of Plasmodium falciparum in a major endemic region of Iran.
Heidari A; Keshavarz H; Rokni MB; Jelinek T
Korean J Parasitol; 2007 Mar; 45(1):59-63. PubMed ID: 17374980
[TBL] [Abstract][Full Text] [Related]
27. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
Carpenter LM; Newton R; Casabonne D; Ziegler J; Mbulaiteye S; Mbidde E; Wabinga H; Jaffe H; Beral V
Int J Cancer; 2008 Mar; 122(6):1319-23. PubMed ID: 18000823
[TBL] [Abstract][Full Text] [Related]
29. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium falciparum: sequence diversity and antibody recognition of the Merozoite surface protein-2 (MSP-2) in Brazilian Amazonia.
Tonon AP; Hoffmann EH; Silveira LA; Ribeiro AG; Gonçalves CR; Ribolla PE; Wunderlich G; Ferreira MU
Exp Parasitol; 2004; 108(3-4):114-25. PubMed ID: 15582508
[TBL] [Abstract][Full Text] [Related]
31. Synergistic Protective Effect of Sickle Cell Trait and Blood Group-O on the Risk of Endemic Burkitt's Lymphoma.
Ahamed SG; Ibrahim UA; Kagu MB
Gulf J Oncolog; 2018 Sep; 1(28):11-16. PubMed ID: 30344128
[TBL] [Abstract][Full Text] [Related]
32. Synthetic Antigens Derived from
Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
[TBL] [Abstract][Full Text] [Related]
33. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.
Da Silveira LA; Dorta ML; Kimura EA; Katzin AM; Kawamoto F; Tanabe K; Ferreira MU
Infect Immun; 1999 Nov; 67(11):5906-16. PubMed ID: 10531247
[TBL] [Abstract][Full Text] [Related]
34. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.
Villasis E; Lopez-Perez M; Torres K; Gamboa D; Neyra V; Bendezu J; Tricoche N; Lobo C; Vinetz JM; Lustigman S
Malar J; 2012 Oct; 11():361. PubMed ID: 23110555
[TBL] [Abstract][Full Text] [Related]
35. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer.
Mulama DH; Bailey JA; Foley J; Chelimo K; Ouma C; Jura WG; Otieno J; Vulule J; Moormann AM
Int J Cancer; 2014 Feb; 134(3):645-53. PubMed ID: 23832374
[TBL] [Abstract][Full Text] [Related]
36. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
37. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.
Helb DA; Tetteh KK; Felgner PL; Skinner J; Hubbard A; Arinaitwe E; Mayanja-Kizza H; Ssewanyana I; Kamya MR; Beeson JG; Tappero J; Smith DL; Crompton PD; Rosenthal PJ; Dorsey G; Drakeley CJ; Greenhouse B
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4438-47. PubMed ID: 26216993
[TBL] [Abstract][Full Text] [Related]
38. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
[TBL] [Abstract][Full Text] [Related]
39. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
[TBL] [Abstract][Full Text] [Related]
40. Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.
Ateba-Ngoa U; Jones S; Zinsou JF; Honkpehedji J; Adegnika AA; Agobe JC; Massinga-Loembe M; Mordmüller B; Bousema T; Yazdanbakhsh M
Am J Trop Med Hyg; 2016 Aug; 95(2):394-400. PubMed ID: 27273645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
